It is a legally mandated obligation for each pharma company to track PV agreements and contracts relating to pharmaceutical products and the exchange of Adverse Events.
Rather than being a requirement that can be met by a stand-alone contracts management system, this requirement is more complex. The CARA Life Sciences Platform allows for the interaction of these contracts with the Pharmacovigilance domain, ensuring consistency and accuracy of data, and reducing manual input and tracking.
